PINK1-parkin-mediated neuronal mitophagy deficiency in prion disease.
PINK1-parkin-mediated neuronal mitophagy deficiency in prion disease.
复制标题
朊病毒病中PINK1 - 帕金(Parkin)介导的神经元线粒体自噬缺陷 。
DOI:
10.1038/s41419-022-04613-2
复制
发表时间:
2022-02-18
影响因子:
9
通讯作者:
Yang L
中科院分区:
文献类型:
--
作者:
Li J;Lai M;Zhang X;Li Z;Yang D;Zhao M;Wang D;Sun Z;Ehsan S;Li W;Gao H;Zhao D;Yang L
A persistent accumulation of damaged mitochondria is part of prion disease pathogenesis. Normally, damaged mitochondria are cleared via a major pathway that involves the E3 ubiquitin ligase parkin and PTEN-induced kinase 1 (PINK1) that together initiate mitophagy, recognize and eliminate damaged mitochondria. However, the precise mechanisms underlying mitophagy in prion disease remain largely unknown. Using prion disease cell models, we observed PINK1-parkin-mediated mitophagy deficiency in which parkin depletion aggravated blocked mitochondrial colocalization with LC3-II-labeled autophagosomes, and significantly increased mitochondrial protein levels, which led to inhibited mitophagy. Parkin overexpression directly induced LC3-II colocalization with mitochondria and alleviated defective mitophagy. Moreover, parkin-mediated mitophagy was dependent on PINK1, since PINK1 depletion blocked mitochondrial Parkin recruitment and reduced optineurin and LC3-II proteins levels, thus inhibiting mitophagy. PINK1 overexpression induced parkin recruitment to the mitochondria, which then stimulated mitophagy. In addition, overexpressed parkin and PINK1 also protected neurons from apoptosis. Furthermore, we found that supplementation with two mitophagy-inducing agents, nicotinamide mononucleotide (NMN) and urolithin A (UA), significantly stimulated PINK1-parkin-mediated mitophagy. However, compared with NMN, UA could not alleviate prion-induced mitochondrial fragmentation and dysfunction, and neuronal apoptosis. These findings show that PINK1-parkin-mediated mitophagy defects lead to an accumulation of damaged mitochondria, thus suggesting that interventions that stimulate mitophagy may be potential therapeutic targets for prion diseases.
登录
查看更多内容
影响因子:
4.8
作者:
Gu, YP;Fujioka, H;Singh, N
通讯作者:
Singh, N
DOI:
10.1196/annals.1299.114
发表时间:
2003-01-01
期刊:
APOPTOSIS: FROM SIGNALING PATHWAYS TO THERAPEUTIC TOOLS
影响因子:
--
作者:
Corsaro, A;Thellung, S;Florio, T
通讯作者:
Florio, T
DOI:
10.1007/s00018-015-2087-8
发表时间:
2016-02
期刊:
Cellular and molecular life sciences : CMLS
影响因子:
--
作者:
Hamacher-Brady A;Brady NR
通讯作者:
Brady NR
影响因子:
16
作者:
Heo JM;Ordureau A;Paulo JA;Rinehart J;Harper JW
通讯作者:
Harper JW
影响因子:
64.8
作者:
Hoshino, Atsushi;Wang, Wei-jia;Arany, Zoltan
通讯作者:
Arany, Zoltan